![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: AKAP12 |
Gene summary for AKAP12 |
![]() |
Gene information | Species | Human | Gene symbol | AKAP12 | Gene ID | 9590 |
Gene name | A-kinase anchoring protein 12 | |
Gene Alias | AKAP250 | |
Cytomap | 6q25.1 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | Q02952 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9590 | AKAP12 | AEH-subject2 | Human | Endometrium | AEH | 1.15e-02 | 2.86e-02 | -0.2525 |
9590 | AKAP12 | AEH-subject3 | Human | Endometrium | AEH | 3.27e-05 | -1.46e-01 | -0.2576 |
9590 | AKAP12 | AEH-subject4 | Human | Endometrium | AEH | 2.27e-02 | 7.66e-02 | -0.2657 |
9590 | AKAP12 | AEH-subject5 | Human | Endometrium | AEH | 1.70e-03 | -1.33e-01 | -0.2953 |
9590 | AKAP12 | EEC-subject1 | Human | Endometrium | EEC | 4.33e-04 | -1.40e-01 | -0.2682 |
9590 | AKAP12 | EEC-subject2 | Human | Endometrium | EEC | 1.46e-05 | -3.60e-02 | -0.2607 |
9590 | AKAP12 | EEC-subject3 | Human | Endometrium | EEC | 1.67e-04 | -1.29e-01 | -0.2525 |
9590 | AKAP12 | EEC-subject4 | Human | Endometrium | EEC | 6.35e-05 | -1.50e-01 | -0.2571 |
9590 | AKAP12 | EEC-subject5 | Human | Endometrium | EEC | 2.27e-06 | -1.72e-01 | -0.249 |
9590 | AKAP12 | GSM5276934 | Human | Endometrium | EEC | 3.90e-37 | 8.73e-01 | -0.0913 |
9590 | AKAP12 | GSM5276937 | Human | Endometrium | EEC | 4.24e-57 | 1.31e+00 | -0.0897 |
9590 | AKAP12 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 5.49e-06 | -1.48e-01 | -0.1869 |
9590 | AKAP12 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 2.13e-05 | -2.03e-01 | -0.1875 |
9590 | AKAP12 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 1.12e-06 | -2.03e-01 | -0.1883 |
9590 | AKAP12 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 1.85e-09 | -1.96e-01 | -0.1934 |
9590 | AKAP12 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 2.65e-11 | -1.60e-01 | -0.1917 |
9590 | AKAP12 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 9.79e-09 | -1.65e-01 | -0.1916 |
9590 | AKAP12 | P4T-E | Human | Esophagus | ESCC | 8.68e-10 | 3.56e-01 | 0.1323 |
9590 | AKAP12 | P8T-E | Human | Esophagus | ESCC | 4.67e-07 | 3.46e-01 | 0.0889 |
9590 | AKAP12 | P11T-E | Human | Esophagus | ESCC | 1.86e-10 | 9.50e-01 | 0.1426 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000166710 | Endometrium | AEH | ameboidal-type cell migration | 90/2100 | 475/18723 | 3.73e-07 | 1.57e-05 | 90 |
GO:00434105 | Endometrium | AEH | positive regulation of MAPK cascade | 84/2100 | 480/18723 | 2.19e-05 | 4.25e-04 | 84 |
GO:000223710 | Endometrium | AEH | response to molecule of bacterial origin | 65/2100 | 363/18723 | 9.00e-05 | 1.30e-03 | 65 |
GO:003249610 | Endometrium | AEH | response to lipopolysaccharide | 62/2100 | 343/18723 | 9.82e-05 | 1.41e-03 | 62 |
GO:00107616 | Endometrium | AEH | fibroblast migration | 14/2100 | 47/18723 | 4.51e-04 | 4.76e-03 | 14 |
GO:007135610 | Endometrium | AEH | cellular response to tumor necrosis factor | 41/2100 | 229/18723 | 1.66e-03 | 1.36e-02 | 41 |
GO:003461210 | Endometrium | AEH | response to tumor necrosis factor | 44/2100 | 253/18723 | 2.08e-03 | 1.61e-02 | 44 |
GO:00018198 | Endometrium | AEH | positive regulation of cytokine production | 71/2100 | 467/18723 | 4.76e-03 | 3.02e-02 | 71 |
GO:00705555 | Endometrium | AEH | response to interleukin-1 | 26/2100 | 143/18723 | 8.78e-03 | 4.78e-02 | 26 |
GO:000166716 | Endometrium | EEC | ameboidal-type cell migration | 91/2168 | 475/18723 | 7.87e-07 | 2.80e-05 | 91 |
GO:004341011 | Endometrium | EEC | positive regulation of MAPK cascade | 89/2168 | 480/18723 | 4.21e-06 | 1.08e-04 | 89 |
GO:000223714 | Endometrium | EEC | response to molecule of bacterial origin | 68/2168 | 363/18723 | 3.96e-05 | 6.64e-04 | 68 |
GO:003249614 | Endometrium | EEC | response to lipopolysaccharide | 65/2168 | 343/18723 | 4.04e-05 | 6.75e-04 | 65 |
GO:007135615 | Endometrium | EEC | cellular response to tumor necrosis factor | 45/2168 | 229/18723 | 2.54e-04 | 2.94e-03 | 45 |
GO:003461215 | Endometrium | EEC | response to tumor necrosis factor | 48/2168 | 253/18723 | 3.77e-04 | 4.03e-03 | 48 |
GO:001076112 | Endometrium | EEC | fibroblast migration | 14/2168 | 47/18723 | 6.25e-04 | 6.14e-03 | 14 |
GO:000181913 | Endometrium | EEC | positive regulation of cytokine production | 73/2168 | 467/18723 | 4.64e-03 | 2.97e-02 | 73 |
GO:007055511 | Endometrium | EEC | response to interleukin-1 | 27/2168 | 143/18723 | 6.99e-03 | 4.01e-02 | 27 |
GO:0051767 | Endometrium | EEC | nitric-oxide synthase biosynthetic process | 7/2168 | 21/18723 | 7.38e-03 | 4.15e-02 | 7 |
GO:0051769 | Endometrium | EEC | regulation of nitric-oxide synthase biosynthetic process | 7/2168 | 21/18723 | 7.38e-03 | 4.15e-02 | 7 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AKAP12 | SNV | Missense_Mutation | rs775450726 | c.4432G>A | p.Asp1478Asn | p.D1478N | Q02952 | protein_coding | tolerated(0.06) | benign(0.003) | TCGA-D7-A6EY-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
AKAP12 | SNV | Missense_Mutation | rs149275104 | c.2656N>A | p.Glu886Lys | p.E886K | Q02952 | protein_coding | tolerated(1) | benign(0) | TCGA-HU-A4G8-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | SD |
AKAP12 | SNV | Missense_Mutation | c.3340N>A | p.Gln1114Lys | p.Q1114K | Q02952 | protein_coding | tolerated(0.07) | benign(0.086) | TCGA-HU-A4GD-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | mitomycin | PD | |
AKAP12 | SNV | Missense_Mutation | rs766910226 | c.2846N>T | p.Thr949Met | p.T949M | Q02952 | protein_coding | tolerated(0.14) | benign(0.107) | TCGA-HU-A4GQ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
AKAP12 | SNV | Missense_Mutation | c.4757A>G | p.Asp1586Gly | p.D1586G | Q02952 | protein_coding | deleterious(0.01) | possibly_damaging(0.475) | TCGA-HU-A4GX-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | taxol | SD | |
AKAP12 | SNV | Missense_Mutation | c.5171N>G | p.Thr1724Ser | p.T1724S | Q02952 | protein_coding | tolerated(0.18) | benign(0.03) | TCGA-HU-A4HD-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
AKAP12 | SNV | Missense_Mutation | novel | c.5273N>T | p.Ala1758Val | p.A1758V | Q02952 | protein_coding | deleterious(0) | benign(0.065) | TCGA-VQ-A91E-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
AKAP12 | SNV | Missense_Mutation | novel | c.4816N>G | p.Gln1606Glu | p.Q1606E | Q02952 | protein_coding | tolerated(0.24) | benign(0.003) | TCGA-VQ-A91S-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | fluorouracil | CR |
AKAP12 | insertion | Frame_Shift_Ins | rs767490652 | c.2838_2839insC | p.Thr949HisfsTer4 | p.T949Hfs*4 | Q02952 | protein_coding | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | ||
AKAP12 | insertion | Frame_Shift_Ins | novel | c.3473_3474insC | p.Asp1161Ter | p.D1161* | Q02952 | protein_coding | TCGA-HU-A4GQ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |